O

Option Care Health

Largest independent home infusion therapy provider

Pharmacy Manager

Full-Time
$131k - $218.4k
Senior
Bachelor's
Shreveport, LA, USA
In Person
Medical, Clinical & VeterinaryPharmacy

About the job

Requirements
  • Graduate of an accredited school of pharmacy.
  • Hold a current, active pharmacy license granted by the State Board of Pharmacy.
  • Have at least 5 to 7 years of experience in a clean room or infusion pharmacy setting, or 3 years of experience plus knowledge of non-sterile compounding and medication therapy management, completion of an ASHP-accredited Pharmacy Residency Program, or equivalent experience approved by the VP of Pharmacy and/or SVP of Clinical Services.
  • Have at least 3 years of experience directly managing people, including hiring, developing, motivating, and directing them.
  • Have at least 2 years of experience planning, developing, and managing departmental expense and capital budgets, or completion of an ASHP-accredited Residency Program or equivalent experience approved by the National Director of Pharmacy and/or VP of Clinical Services.
  • Have experience compounding sterile products and managing patient care.
  • Have experience overseeing purchasing and inventory processes for pharmaceutical and related substances and supplies.
  • Have reliable transportation to make home visits; if using a personal vehicle, hold a valid driver's license and provide proof of insurance.
  • Maintain active membership in a related state or national clinical, pharmaceutical, or home health care organization.
  • Have experience identifying operational issues and recommending and implementing strategies to resolve problems.
  • Have experience providing customer service to internal and external customers, meeting service quality standards, and evaluating customer satisfaction.
  • Have basic skills in Microsoft Word, including editing and formatting documents, using find and replace, spell check, track changes, and print functions.
  • Have basic skills in Microsoft Excel, including workbook editing, cell formatting, sorting, charts, worksheets, page setup, spell check, and printing.
  • Have basic skills in Microsoft PowerPoint, including managing slides, editing text, inserting tables or notes, moving objects, printing outline view, and running slide shows.
  • Be willing to travel up to 5% of the time for business purposes, within and outside the state.
Responsibilities
  • Determine patient suitability for home care and supervise, monitor, and evaluate the quality and effectiveness of patient care provided by pharmacy staff.
  • Manage daily activities to support effective operations and communications.
  • Direct pharmacy department activities and schedule staff work to meet patients' pharmaceutical-care needs.
  • Develop and mentor staff through onboarding, open communication, training, development opportunities, and performance management processes.
  • Oversee product purchasing, inventory, budget, and equipment management.
  • Assist the General Manager in preparing, securing approval for, and implementing operating and expenditure budgets, and operate within those guidelines.
  • Evaluate and oversee the purchasing, management, and security of medications, pumps, and medical supplies in accordance with company policies and formulary guidelines.
  • Support sales professionals and the General Manager by accurately explaining available services and meeting with managed care organizations and other accounts to provide service education.
  • May serve as Office Administrator with the Director of Nursing or Nurse Manager when the General Manager is absent.
  • Collect and organize patient-specific information to prevent, detect, and resolve medication-related problems and make medication therapy recommendations.
  • Monitor clinical staff documentation on pharmacy care plans for home care patients using monitoring data and other relevant patient-specific information.
  • Evaluate competency in the use of pharmacokinetic principles and formulas.
  • Ensure medications are prepared and dispensed using appropriate techniques and company policies; ensure equipment is accurately calibrated and medications are appropriately concentrated, compatible, stable, and stored.
  • Coordinate and participate in pharmacy department on-call responsibilities, ensuring reliable coverage and providing pharmacy services when scheduled.
  • Manage investigational drug products in accordance with regulations and company policies and procedures.
  • Comply with accreditation, legal, regulatory, and safety requirements.
Desired Qualifications
  • Complete a post-graduate residency program in clinical pharmacy services.
  • Hold board certification in Nutrition Support Pharmacy, Pharmacotherapy, or another clinical pharmacy practice area.
  • Have experience managing inventory and logistics.
  • Have at least 5 years of experience compounding sterile products and managing complex infusion patients.
  • Have at least 3 years of experience overseeing purchasing and inventory processes for pharmaceutical and related substances and supplies.

About the company

Option Care Health delivers infusion therapies at home and other alternate-site locations across the United States, supported by over 7,000 teammates including about 4,500 clinicians. Clinicians visit patients at home or approved sites to administer therapies, manage care, and coordinate with care teams under strong clinical leadership and national scale. It stands out as the largest independent infusion provider with nationwide reach and a robust clinical workforce, enabling scalable home and alternate-site infusion rather than hospital-only care. The goal is to elevate standards of care and reimagine the infusion care experience by expanding access, improving outcomes, and delivering compassionate, clinically driven service.

Company Size

1,001-5,000

Company Stage

IPO

Headquarters

Bannockburn, Illinois

Founded

1979

Get referred to Option Care Health

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • July 29, 2026 Q2 revenue reached $1.44 billion, while acute therapy and IG Neuro strengthened.
  • Management stabilized CID patient census in Q2 2026 and kept full-year revenue guidance unchanged.
  • The company repurchased $150 million in Q2 2026, signaling confidence and shareholder-return capacity.

What critics are saying

  • August 2026 guidance still bakes in a 600-basis-point CID revenue headwind and $55 million gross profit hit.
  • July 29, 2026 Q2 buyback of $150 million masks weak top-line momentum and analyst skepticism.
  • Biosimilar erosion and payer reverification pressure can permanently shrink chronic volumes if retention stays broken.

What makes Option Care Health unique

  • Option Care Health leads U.S. independent home and alternate-site infusion, with nationwide clinician density.
  • Its payer, biopharma, and prescriber relationships create switching costs across chronic and acute therapies.
  • August 27, 2026 guidance shows durable cash generation, with at least $320 million operating cash flow.

Help us improve and share your feedback! Did you find this helpful?

Benefits

  • Health Insurance
  • Dental Insurance
  • Vision Insurance
  • Paid Time Off
  • Bonding Time Off
  • 401(k) Retirement Plan
  • 401(k) Company Match
  • Health Savings Account/Flexible Spending Account
  • Flexible Spending Accounts
  • Tuition Reimbursement
  • Family Support
  • Mental Health Support

Company News

AD HOC NEWS
Oct 15th, 2026
McKesson commits $1.4B for 49% stake in Option Care at $5.8B valuation

McKesson will invest $1.4 billion for a 49% minority stake in Option Care Health, under an agreement announced on October 6, 2026. The deal values Option Care at an enterprise value of $5.8 billion. Clayton, Dubilier & Rice will hold about 51%. Option Care will stay separately managed, while McKesson keeps a framework to acquire the remaining interest later, subject to conditions and regulatory approvals. In its first fiscal 2027 quarter, McKesson reported revenue of $105.38 billion, up 7.7% year on year, and adjusted earnings per share of $9.93. It will report second-quarter results on November 4, 2026.

Yahoo Finance
Oct 6th, 2026
McKesson and Clayton Dubilier & Rice near $5B deal to acquire Option Care Health

Option Care Health shares jumped 33.2% in pre-market trading after the Financial Times reported McKesson and Clayton Dubilier & Rice are nearing a transaction valued at over $5 billion to acquire the alternate site health provider. According to the report, the deal would involve the two firms partnering to buy the infusion services provider, which they view as undervalued. Large-scale buyout discussions typically drive market optimism as investors anticipate acquisition premiums. The move is significant for Option Care Health, whose shares have experienced 13 movements greater than 5% over the past year. At $31.03 per share, the stock is trading 15.2% below its 52-week high but remains down 3.8% year-to-date.

Central Charts
Oct 6th, 2026
CD&R and McKesson Corporation Sign Agreement to Acquire Option Care Health

CD&R, McKesson Corporation (NYSE: MCK) (“McKesson”), and Option Care Health, Inc. (Nasdaq: OPCH) (“Option Care Health”) announced today that they have

Yahoo Finance
Jul 29th, 2026
Option Care Health Q2 beats expectations with $1.4B revenue, narrows full-year guidance

Option Care Health reported second-quarter 2026 results that exceeded expectations. Revenue rose 7% sequentially to $1.4 billion, whilst adjusted EBITDA increased 12% to $117.5 million and adjusted EPS reached $0.45. Operating cash flow totalled $184 million. Acute therapies posted high-single-digit organic growth, while chronic revenue improved sequentially as the CID portfolio began to stabilise. However, CID-related pressure is expected to reduce 2026 revenue by roughly 600 basis points and gross profit by $55 million. The home and alternate-site infusion provider maintained its full-year revenue guidance at $5.675 billion to $5.775 billion. Adjusted EBITDA guidance was narrowed to $480 million to $495 million, and adjusted EPS guidance to $1.85 to $1.92. The company repurchased $150 million of shares, nearly 5% of shares outstanding.

Yahoo Finance
Jul 29th, 2026
Option Care Health reports $1.44B Q2 revenue, up 1.9%, and raises $150M share buyback

Option Care Health, the largest independent provider of home and alternate site infusion services in the US, reported second quarter 2026 results. Net revenue reached $1.44 billion, up 1.9% year-over-year. The company posted net income of $53.9 million, up 6.7%, with diluted earnings per share of $0.35, up 12.9%. Adjusted EBITDA grew 3.0% to $117.5 million. The company repurchased $150 million of outstanding shares during the quarter. For full year 2026, Option Care Health expects net revenue between $5.68 billion and $5.78 billion, with adjusted diluted earnings per share of $1.85 to $1.92. The company forecasts adjusted EBITDA of $480 million to $495 million and operating cash flow of at least $320 million.